[1]
“Assessing the Quality of Life and Survival of Iraqi Patients with Metastatic Colorectal Cancer Receiving Bevacizumab   and Chemotherapy”, AJPS, vol. 25, no. 4, pp. 476–492, Oct. 2025, doi: 10.32947/ajps.v25i4.1218.